ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,078Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 107

$572K Total Retail Price of All Prescriptions

Rank: 27 out of 107

454 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

4% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 9,655 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 511 473 1 2
METOPROLOL SUCCINATE 380 376 2 15
LEVOTHYROXINE SODIUM 369 347 3 1
OMEPRAZOLE 335 316 4 6
WARFARIN SODIUM 306 305 5 8
FUROSEMIDE 300 296 6 3
SERTRALINE HCL 273 273 7 12
HYDROCHLOROTHIAZIDE 271 268 8 14
ATORVASTATIN CALCIUM 243 231 9 17
LISINOPRIL 197 189 10 4
LOSARTAN POTASSIUM 181 164 11 36
AMLODIPINE BESYLATE 175 166 12 5
METOPROLOL TARTRATE 168 168 13 7
NEXIUM 132 132 14 61
PANTOPRAZOLE SODIUM 124 124 15 28
DIGOXIN 124 124 15 37
FAMOTIDINE 120 116 17 42
ATENOLOL 118 110 18 21
ENALAPRIL MALEATE 114 111 19 70
METFORMIN HCL ER 107 102 20 207
ZOLPIDEM TARTRATE 106 94 21 38
POTASSIUM CHLORIDE 97 97 22 18
CITALOPRAM HBR 88 88 23 9
PRAVASTATIN SODIUM 88 84 23 32
DONEPEZIL HCL 86 86 25 10
GABAPENTIN 86 83 25 11
CRESTOR 85 83 27 63
SPIRONOLACTONE 84 84 28 74
RAMIPRIL 83 83 29 134
ADVAIR DISKUS 79 79 30 47
FLUTICASONE PROPIONATE 79 66 30 54
SOTALOL 76 76 32 226
ISOSORBIDE MONONITRATE ER 74 68 33 30
LANTUS 73 69 34 34
BENICAR 72 72 35 183
RISPERIDONE 71 71 36 26
CELEBREX 68 68 37 82
PREDNISONE 65 65 38 39
LOVAZA 62 50 39 138
LOVASTATIN 59 59 40 51
METFORMIN HCL 58 58 41 13
ZETIA 56 52 42 126
NOVOLOG 55 55 43 76
NAMENDA 55 55 43 19
ALLOPURINOL 55 50 43 48
SYNTHROID 54 54 46 85
HYDROCODONE-ACETAMINOPHEN 53 53 S3 47 20
CIPROFLOXACIN HCL 52 50 48 73
QUINAPRIL HCL 51 50 49 192
JANUVIA 51 47 49 71
DILTIAZEM 24HR ER 50 50 51 158
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.